Cargando…

Multimodal Treatment of Advanced Mucosal Melanoma in the Era of Modern Immunotherapy

SIMPLE SUMMARY: Immunotherapy revolutionized the treatment of cutaneous melanoma and greatly improved treatment outcomes in this group of patients. Mucosal melanoma is a rare disease, biologically distinct from the cutaneous subtype. There is little real-world data on immunotherapy efficacy in mucos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teterycz, Pawel, Czarnecka, Anna M., Indini, Alice, Spałek, Mateusz J., Labianca, Alice, Rogala, Pawel, Cybulska-Stopa, Bożena, Quaglino, Pietro, Ricardi, Umberto, Badellino, Serena, Szumera-Ciećkiewicz, Anna, Falkowski, Slawomir, Mandala, Mario, Rutkowski, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692305/ https://www.ncbi.nlm.nih.gov/pubmed/33114734 http://dx.doi.org/10.3390/cancers12113131

Ejemplares similares

Mutation profile of primary subungual melanomas in Caucasians
por: Borkowska, Aneta, et al.
Publicado: (2020)

Clinicopathological Features and Prognostic Factors of Primary Acral Melanomas in Caucasians
por: Borkowska, Aneta M., et al.
Publicado: (2020)

The Analysis of Trends in Survival for Patients with Melanoma Brain Metastases with Introduction of Novel Therapeutic Options before the Era of Combined Immunotherapy—Multicenter Italian–Polish Report
por: Placzke, Joanna, et al.
Publicado: (2022)

Treatment of Locally Advanced Merkel Cell Carcinoma—A Multi-Center Study
por: Dudzisz-Sledz, Monika, et al.
Publicado: (2022)

Feasibility and Long-Term Efficacy of PEComa Treatment—20 Years of Experience
por: Sobiborowicz, Aleksandra, et al.
Publicado: (2021)

Body mass index (BMI) and outcome of metastatic melanoma patients receiving targeted therapy and immunotherapy: a multicenter international retrospective study
por: Rutkowski, Piotr, et al.
Publicado: (2020)

Epithelioid Sarcoma—From Genetics to Clinical Practice
por: Czarnecka, Anna M., et al.
Publicado: (2020)

Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Follicular Differentiation
por: Płachta, Iga, et al.
Publicado: (2021)

Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Apocrine and Eccrine Differentiation
por: Płachta, Iga, et al.
Publicado: (2021)

Treatment of Malignant Adnexal Tumors of the Skin: A 12-Year Perspective
por: Kleibert, Marcin, et al.
Publicado: (2022)

Efficacy of Sirolimus Treatment in PEComa–10 Years of Practice Perspective
por: Świtaj, Tomasz, et al.
Publicado: (2021)

Efficacy of Neoadjuvant Targeted Therapy for Borderline Resectable III B-D or IV Stage BRAF (V600) Mutation-Positive Melanoma
por: Czarnecka, Anna M., et al.
Publicado: (2021)

Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall: Results of a Single-Arm Prospective Clinical Trial
por: Koseła-Paterczyk, Hanna, et al.
Publicado: (2020)

Merkel Cell Carcinoma from Molecular Pathology to Novel Therapies
por: Stachyra, Karolina, et al.
Publicado: (2021)

Systemic Treatment for Advanced and Metastatic Malignant Peripheral Nerve Sheath Tumors—A Sarcoma Reference Center Experience
por: Sobczuk, Paweł, et al.
Publicado: (2020)

Efficacy and Safety of Hypofractionated Preoperative Radiotherapy for Primary Locally Advanced Soft Tissue Sarcomas of Limbs or Trunk Wall
por: Koseła-Paterczyk, Hanna, et al.
Publicado: (2021)

Chondrosarcoma-from Molecular Pathology to Novel Therapies
por: Zając, Agnieszka E., et al.
Publicado: (2021)

Predictive Biomarkers of Pathological Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Soft Tissue Sarcomas
por: Szumera-Ciećkiewicz, Anna, et al.
Publicado: (2023)

Stereotactic radiotherapy for soft tissue and bone sarcomas: real-world evidence
por: Spałek, Mateusz Jacek, et al.
Publicado: (2022)

The Long-Term Outcomes of Intensive Combined Therapy of Adult Patients with Localised Synovial Sarcoma
por: Kozak, Katarzyna, et al.
Publicado: (2020)

Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or BRAF/MEK Targeted Therapy: Multicenter Real-World Report
por: Placzke, Joanna, et al.
Publicado: (2023)

Results of systemic treatment of cutaneous melanoma in inoperable stage III and IV
por: Cybulska-Stopa, Bożena, et al.
Publicado: (2013)

Molecular Profiling and Novel Therapeutic Strategies for Mucosal Melanoma: A Comprehensive Review
por: Indini, Alice, et al.
Publicado: (2021)

The Management of Radiation-Induced Sarcomas: A Cohort Analysis from a Sarcoma Tertiary Center
por: Spałek, Mateusz Jacek, et al.
Publicado: (2021)

Risk Prediction and New Prophylaxis Strategies for Thromboembolism in Cancer
por: Labianca, Alice, et al.
Publicado: (2020)

Definitive Radiotherapy in the Management of Non-Resectable or Residual Retroperitoneal Sarcomas: Institutional Cohort Analysis and Systematic Review
por: Sobiborowicz, Aleksandra, et al.
Publicado: (2021)

The Current Treatment Trends and Survival Patterns in Melanoma Patients with Positive Sentinel Lymph Node Biopsy (SLNB): A Multicenter Nationwide Study
por: Ziętek, Marcin, et al.
Publicado: (2023)

Acral lentiginous melanoma histotype predicts outcome in clinical stage I-II melanoma patients: an International multicenter study
por: Mandalà, M., et al.
Publicado: (2022)

Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma Patients
por: Rogala, Paweł, et al.
Publicado: (2022)

Radiotherapy in the Management of Pediatric and Adult Osteosarcomas: A Multi-Institutional Cohort Analysis
por: Spałek, Mateusz Jacek, et al.
Publicado: (2021)

Myocarditis Induced by Immunotherapy in Metastatic Melanoma—Review of Literature and Current Guidelines
por: Czarnecka, Anna M., et al.
Publicado: (2022)

Denosumab in Giant Cell Tumor of Bone: Multidisciplinary Medical Management Based on Pathophysiological Mechanisms and Real-World Evidence
por: Borkowska, Aneta Maria, et al.
Publicado: (2022)

Differential HLA class I subunit (A, B, C heavy chain and β(2)-microglobulin) expression levels in normal tissues
por: Ugolini, Filippo, et al.
Publicado: (2022)

Long-Term Outcomes of Targeted Therapy after First-Line Immunotherapy in BRAF-Mutated Advanced Cutaneous Melanoma Patients—Real-World Evidence
por: Rogala, Paweł, et al.
Publicado: (2022)

Immune checkpoint inhibitors therapy in older patients (≥ 70 years) with metastatic melanoma: a multicentre study
por: Cybulska-Stopa, Bożena, et al.
Publicado: (2019)

Neoadjuvant Treatment Options in Soft Tissue Sarcomas
por: Spałek, Mateusz Jacek, et al.
Publicado: (2020)

Gene expression profiling of peripheral blood cells: new insights into Ewing sarcoma biology and clinical applications
por: Przybyl, Joanna, et al.
Publicado: (2014)

Dedifferentiated Chondrosarcoma from Molecular Pathology to Current Treatment and Clinical Trials
por: Zając, Weronika, et al.
Publicado: (2023)

Principles of prophylactic and therapeutic management of skin toxicity during treatment with checkpoint inhibitors
por: Kamińska-Winciorek, Grażyna, et al.
Publicado: (2019)

Immunotherapy of melanoma
por: Lugowska, Iwona, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dsq4vqr3ckgnrgmse00aerp9v0